Reconsidering the Cancer Center Accreditation Model.

JAMA Oncol

Center for Healthcare Outcomes & Policy, Institute for Healthcare Policy & Innovation, Michigan Medicine, Ann Arbor.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2025.0620DOI Listing

Publication Analysis

Top Keywords

reconsidering cancer
4
cancer center
4
center accreditation
4
accreditation model
4
reconsidering
1
center
1
accreditation
1
model
1

Similar Publications

Female reproductive toxicity after exposure to malathion or diazinon: a systematic review of rodent and human studies.

Crit Rev Toxicol

September 2025

Laboratório de Reprodução e Toxicologia (Laretox), Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil.

Malathion and diazinon are pesticides widely used in agriculture as well as for domestic and veterinary purposes to control pests, such as scale insects, aphids, and fleas. However, these compounds may have harmful effects on the female genital system in humans and animals. This study conducted a systematic review of the scientific literature on the female reproductive effects in humans and rodents exposed to malathion or diazinon.

View Article and Find Full Text PDF

Introduction: Although Interleukin (IL)-6-type cytokine signaling is critical for maintaining the body's homeostasis, aberrant signaling has been observed in numerous diseases including autoimmunity and cancer. Currently, all approved biologics that inhibit IL-6-type cytokines specifically target the key pro-inflammatory mediator IL-6 or its receptor (IL6R). Historically, direct inhibition of glycoprotein 130 (gp130)-the shared transmembrane receptor for IL-6-type cytokines-was avoided due to concerns that broad suppression might cause more harm than benefit.

View Article and Find Full Text PDF

Exposure to low levels of hexavalent chromium in drinking water alters diet-induced steatotic liver disease in male rats.

J Trace Elem Med Biol

August 2025

Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.

Ranked as a "top 10 cause of death", chronic liver disease accounts for millions of deaths annually. The prevalence of the most prominent liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), has doubled over the past 20 years and continues to rise. Growing in parallel are environmental chemical exposures, emergingas key risk factors for liver disease.

View Article and Find Full Text PDF